文献速递认知障碍与痴呆

阿尔茨海默病患者额叶伽马活动降低

Decreased Frontal Gamma Activity in Alzheimer Disease Patients.
PubMed 文献 · Ann Neurol · 2022-07-07

本研究采用经颅磁刺激-脑电图(TMS-EEG)技术,在60例轻中度阿尔茨海默病(AD)患者和21名年龄匹配健康志愿者中评估左侧背外侧前额叶皮层、楔前叶和左侧后顶叶皮层的皮层振荡。结果显示AD患者额叶伽马活动较健康志愿者显著降低,且额叶伽马活动降低更明显的AD患者长时程增强样可塑性受损更重、24周随访时认知下降更明显。

要点

  • AD患者额叶伽马活动较年龄匹配健康志愿者显著降低。
  • 额叶伽马活动降低更明显的AD患者长时程增强样可塑性受损更重。
  • 额叶伽马活动降低更明显的AD患者24周随访时认知下降更明显。

核心结论

  • AD患者额叶伽马活动降低,TMS-EEG有望用于测量AD患者个体额叶伽马活动,该指标可能作为预测疾病进展和评估新药治疗反应的生物标志物。

研究设计与样本

  • 研究纳入60例轻中度AD患者和21名年龄匹配健康志愿者,均接受3次TMS-EEG会话以评估左侧背外侧前额叶皮层、楔前叶和左侧后顶叶皮层的皮层振荡。
  • AD患者在基线接受基于TMS的神经生理学特征描述和认知评估,认知评估在24周后重复以监测临床演变。

主要发现

  • AD患者额叶伽马活动较年龄匹配健康志愿者显著降低。
  • 额叶伽马活动降低更明显的AD患者长时程增强样可塑性受损更重。
  • 额叶伽马活动降低更明显的AD患者在24周随访时认知下降更明显。

临床怎么用

  • 作者认为TMS-EEG是测量AD患者个体额叶伽马活动的有前景技术,该指标可能作为预测疾病进展和评估新药治疗反应的生物标志物。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In Alzheimer disease (AD) animal models, synaptic dysfunction has recently been linked to a disorder of high-frequency neuronal activity. In patients, a clear relation between AD and oscillatory activity remains elusive. Here, we attempt to shed light on this relation by using a novel approach combining transcranial magnetic stimulation and electroencephalography (TMS-EEG) to probe oscillatory activity in specific hubs of the frontoparietal network in a sample of 60 mild-to-moderate AD patients. METHODS: Sixty mild-to-moderate AD patients and 21 age-matched healthy volunteers (HVs) underwent 3 TMS-EEG sessions to assess cortical oscillations over the left dorsolateral prefrontal cortex, the precuneus, and the left posterior parietal cortex. To investigate the relations between oscillatory activity, cortical plasticity, and cognitive decline, AD patients underwent a TMS-based neurophysiological characterization and a cognitive evaluation at baseline. The latter was repeated after 24 weeks to monitor clinical evolution. RESULTS: AD patients showed a significant reduction of frontal gamma activity as compared to age-matched HVs. In addition, AD patients with a more prominent decrease of frontal gamma activity showed a stronger impairment of long-term potentiation-like plasticity and a more pronounced cognitive decline at subsequent follow-up evaluation at 24 weeks. INTERPRETATION: Our data provide novel evidence that frontal lobe gamma activity is dampened in AD patients. The current results point to the TMS-EEG approach as a promising technique to measure individual frontal gamma activity in patients with AD. This index could represent a useful biomarker to predict disease progression and to evaluate response to novel pharmacological therapies. ANN NEUROL 2022;92:464-475.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Casula EP, Pellicciari MC, Bonnì S, et al. Decreased Frontal Gamma Activity in Alzheimer Disease Patients. Ann Neurol. 2022. PMID: 35713198. doi:10.1002/ana.26444

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。